| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |